NCT07539519

Brief Summary

This pilot study is funded by the Organization for Autism Research (OAR). We are conducting a pilot study to improve mental health treatment for autistic individuals. First, we will conduct remote focus groups to identify barriers to mental health treatment and methods to improve treatment. Based on results, we will develop a prototype of a resource for therapists. This resource will be pilot tested in a community clinic.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
19mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Apr 2026Dec 2027

Study Start

First participant enrolled

April 1, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 3, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

1.7 years

First QC Date

April 3, 2026

Last Update Submit

April 13, 2026

Conditions

Keywords

mental health treatment

Outcome Measures

Primary Outcomes (3)

  • Acceptability of Intervention Measure

    The Acceptability of Intervention Measure includes four items rated on a five-point scale (1= "Completely Disagree"; 5 = "Completely Agree"). Items are averaged to produce an acceptability score. Higher scores indicate greater acceptability.

    Baseline and 1 month

  • Feasibility of Intervention Measure

    The Feasibility of Intervention Measure includes four items rated on a five-point scale (1= "Completely Disagree"; 5 = "Completely Agree"). Items are averaged to produce a feasibility score. Higher scores indicate greater feasibility.

    Baseline and 1 month

  • Intervention Appropriateness Measure

    The Intervention Appropriateness Measure includes four items rated on a five-point scale (1= "Completely Disagree"; 5 = "Completely Agree"). Items are averaged to produce an appropriateness score. Higher scores indicate greater appropriateness of the resource.

    Baseline and 1 month

Secondary Outcomes (5)

  • Autism Spectrum Knowledge Scale Professional Version - Revised

    Baseline and 1 month

  • Therapist Confidence Scale (TCS) - adapted for autism

    Baseline and 1 month

  • Client Satisfaction Questionnaire

    Baseline and 4 months

  • Goal Attainment Scaling

    Baseline and 4 months

  • Clinical Global Impressions

    Baseline and 4 months

Study Arms (2)

Treatment as usual

ACTIVE COMPARATOR

Clients will continue to receive psychotherapy

Behavioral: Treatment as Usual (TAU)

Enhanced Psychotherapy

EXPERIMENTAL

Clients will receive psychotherapy from therapists who have access to a toolkit that reviews ways to adapt evidence-based interventions for autistic clients.

Behavioral: Enhanced Psychotherapy

Interventions

Clients randomized to the Enhanced Psychotherapy group will receive psychotherapy from therapists who have access to a toolkit that reviews strategies for tailoring evidence-based therapy to improve mental health treatment for autistic individuals.

Enhanced Psychotherapy

Clients randomized to this condition will continue to receive psychotherapy in a community clinic

Treatment as usual

Eligibility Criteria

Age13 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • A confirmed diagnosis of autism
  • Between 13 and 17 years old
  • Fluent in English
  • Have a co-occurring mental health condition that is appropriate for treatment at the community clinic participating in the proposed study

You may not qualify if:

  • N/A
  • All therapists working at the community clinic at which this study takes place will be eligible to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida International University

Miami, Florida, 33199, United States

Location

MeSH Terms

Conditions

Autistic Disorder

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Yael Dai, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
In the clinical trial, the 12 autistic clients will be masked to their and their their therapist's condition. The 6 therapists will know whether they are randomized to the intervention or treatment as usual (TAU) group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2026

First Posted

April 20, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

April 20, 2026

Record last verified: 2026-04

Locations